Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer

Sponsor
Radiation Therapy Oncology Group (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT00956007
Collaborator
National Cancer Institute (NCI) (NIH), NRG Oncology (Other)
703
264
2
201
2.7
0

Study Details

Study Description

Brief Summary

RATIONALE: Giving radiation therapy that uses a 3-dimensional (3-D) image of the tumor to help focus thin beams of radiation directly on the tumor, and giving radiation therapy in higher doses over a shorter period of time, may kill more tumor cells and have fewer side effects. Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. It is not yet known whether radiation therapy is more effective when given alone or together with cetuximab in treating patients with head and neck cancer that has been removed by surgery.

PURPOSE: This randomized phase III trial is studying radiation therapy to see how well it works compared with radiation therapy given together with cetuximab in treating patients who have undergone surgery for locally advanced head and neck cancer.

Condition or Disease Intervention/Treatment Phase
  • Biological: cetuximab
  • Radiation: intensity-modulated radiation therapy
Phase 3

Detailed Description

OBJECTIVES:

Primary

  • Determine whether the addition of cetuximab to postoperative intensity-modulated radiotherapy (IMRT) will improve overall survival (OS) in patients with locally advanced squamous cell carcinoma of the head and neck at intermediate risk following surgery.

Secondary

  • Assess the impact of the addition of cetuximab to postoperative IMRT on disease-free survival (DFS) of these patients.

  • Assess the impact of the addition of cetuximab to postoperative IMRT on acute and late dysphagia, xerostomia, skin toxicity, and other toxicities according to common Toxicity Criteria for Adverse Effects (CTCAE), v. 4 and their relationships with patient-reported outcomes at 3, 12, and 24 months.

  • Analyze tumor for epidermal growth factor receptor (EGFR), specifically the extent of EGFR overexpression by immuno-histochemistry (IHC) and FISH analysis, EGFRvIII expression, as well as the association of these assay data with OS and DFS.

  • Analyze tumor for human papillomavirus (HPV) infection (as defined by in situ hybridization), specifically, within the cohort of patients with oropharynx cancer, to perform an exploratory analysis of the impact of HPV on DFS and OS of this patient subset.

  • Analyze tumor DNA for TP53 mutations as a predictor of response to cetuximab and prognosis.

  • Analyze germline DNA of polymorphic variants in EGFR intron repeats as a predictor of response to cetuximab.

Tertiary

  • Assess the impact of the addition of cetuximab to postoperative IMRT on loco-regional control.

  • Assess the impact of the addition of cetuximab to postoperative IMRT on patient-reported quality of life, swallowing, xerostomia, and skin toxicity based on head and neck specific instruments, including the Performance Status Scale for Head and Neck Cancer (PSS-HN), the Functional Assessment of Cancer Therapy-Head & Neck (FACT-H&N), the University of Michigan Xerostomia-Related Quality of Life Scale (XeQOLS), and the Dermatology Life Quality Index (DLQI).

  • Assess the impact of the addition of cetuximab to postoperative IMRT on cost-utility analysis using the EuroQol (EQ-5D).

  • Evaluate the utility of image-guided radiotherapy (IGRT) as a means of enhancing the efficacy (i.e., loco-regional control) of IMRT while reducing the acute and/or late toxicity (particularly xerostomia) and improving patient-reported outcomes (particularly XeQOLS scores).

  • Retrospectively compare the loco-regional control rate in patients treated with IMRT alone (no IGRT or cetuximab) with similar patients treated with external beam radiotherapy alone in the postoperative clinical trial Radiation Therapy Oncology Group (RTOG)-95 01.

OUTLINE: This is a multicenter study. Patients are stratified according to clinical stage (T2-3 vs T4a), EGFR expression (high [≥ 80% of cells staining positive] vs low [< 80% of cells staining positive] vs not evaluable), primary site of disease (oral cavity vs larynx vs oropharynx p16+ vs oropharynx p16- vs oropharynx, p16 not evaluable), and use of image-guided radiotherapy (yes vs no). Patients are randomized to 1 of 2 treatment arms.

  • Arm I: Patients undergo intensity-modulated radiotherapy (IMRT) once daily 5 days a week for 6 weeks in the absence of disease progression or unacceptable toxicity.

  • Arm II: Patients undergo IMRT as in arm I. Patients also receive cetuximab IV over 1-2 hours once weekly beginning at least 5 days prior to the start of IMRT and continuing for 4 weeks after the completion of IMRT (for a total of 11 doses) in the absence of disease progression or unacceptable toxicity.

Quality of life is assessed at baseline and at 3, 12, and 24 months.

Tissue samples are collected periodically for further laboratory analysis.

After completion of study treatment, patients are followed up at 1 and 3 months, every 3 months for 2 years, every 6 months for 3 years, and then annually thereafter.

Study Design

Study Type:
Interventional
Actual Enrollment :
703 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer
Actual Study Start Date :
Nov 1, 2009
Anticipated Primary Completion Date :
Dec 1, 2022
Anticipated Study Completion Date :
Aug 1, 2026

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Arm I: Intensity-Modulated Radiotherapy

Patients undergo intensity-modulated radiotherapy (IMRT) once daily 5 days a week for 6 weeks in the absence of disease progression or unacceptable toxicity.

Radiation: intensity-modulated radiation therapy
Patients undergo radiotherapy.

Experimental: Arm II: IMRT plus cetuximab

Patients undergo IMRT as in arm I. Patients also receive cetuximab IV over 1-2 hours once weekly beginning at least 5 days prior to the start of IMRT and continuing for 4 weeks after the completion of IMRT (for a total of 11 doses) in the absence of disease progression or unacceptable toxicity.

Biological: cetuximab
Given IV

Radiation: intensity-modulated radiation therapy
Patients undergo radiotherapy.

Outcome Measures

Primary Outcome Measures

  1. Overall survival [From randomization to date of death or last follow-up. Analysis occurs after 372 events have been reported.]

Secondary Outcome Measures

  1. Adverse events (dysphagia, xerostomia, and skin toxicity) according to CTCAE, v. 4 and their relationships with patient-reported outcomes at 3, 12, and 24 months [From start of treatment to 2 years after end of treatment.]

  2. Other acute adverse events (≤ 90 days from start of radiotherapy [RT]) according to CTCAE, v. 4 [From start of treatment to 90 days.]

  3. Other late adverse events (> 90 days from start of RT) according to CTCAE, v. 4 [From 90 days after start of treatment to last follow-up.]

  4. Disease-free survival [From randomization to date of failure (local, regional or distant progression or death) or last follow-up. Analysis occurs at the same time as the primary outcome.]

  5. Loco-regional control [From randomization to date of failure (local or regional progression or distant progression or death) or last follow-up. Analysis occurs at the same time as the primary outcome.]

  6. Quality of life as measured by Functional Assessment of Cancer Therapy-Head & Neck (FACT-HN) and EuroQol (EQ-5D) at baseline and at 3, 12, and 24 months [From randomization to 2 years.]

  7. Xerostomia as measured by University of Michigan Xerostomia-Related Quality of Life Scale (XeQOLS) at baseline and at 3, 12, and 24 months [From randomization to 2 years.]

  8. Swallowing as measured by the normalcy of diet subscale of the Performance Status Scale for Head and Neck Cancer (PSS-HN) at baseline and at 3, 12, and 24 months [From randomization to 2 years.]

  9. Skin toxicity as measured by the Dermatology Life Quality Index (DLQI) at baseline and at 3, 12, and 24 months [From randomization to 2 years.]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
DISEASE CHARACTERISTICS:
  • Histologically confirmed squamous cell carcinoma (including variants, such as verrucous carcinoma, spindle cell carcinoma, or carcinoma not otherwise specified) of the head and neck, including the following subtypes:

  • Oral cavity

  • Oropharynx

  • Larynx

  • Clinical stage T1, N1-2, M0 OR T2-4a, N0-2, M0 disease based on the following diagnostic workup within the past 8 weeks:

  • General history and physical examination by a Radiation Oncologist and/or Medical Oncologist

  • Chest x-ray or chest CT scan (with or without contrast) or chest CT/PET scan (with or without contrast)

  • Must have undergone gross total resection of the primary tumor with curative intent within the past 7 weeks with surgical pathology demonstrating ≥ 1 of the following criteria for "intermediate" risk of recurrence:

  • Perineural invasion

  • Lymphovascular invasion

  • Single lymph node > 3 cm or ≥ 2 lymph nodes (all < 6 cm) (no extracapsular extension)

  • Close margin(s) of resection, defined as cancer extending to within 5 mm of a surgical margin, and/or an initially focally positive margin that is subsequently superseded by intraoperative negative margins (similarly, patients whose tumors had focally positive margins in the main specimen but negative margins from re-excised samples in the region of the positive margin are eligible)

  • Pathologically confirmed T3 or T4a primary tumor

  • T2 oral cavity cancer with > 5 mm depth of invasion

  • No positive margin(s) (defined as tumor present at the cut or inked edge of the tumor), nodal extracapsular extension, and/or gross residual disease after surgery

PATIENT CHARACTERISTICS:
  • Zubrod performance status 0-1

  • Absolute granulocyte count ≥ 1,500/mm³

  • Platelet count ≥ 100,000/mm³

  • Hemoglobin ≥ 8.0 g/dL (transfusion or other intervention allowed)

  • Total bilirubin < 2 times upper limit of normal (ULN)

  • Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) < 3 times ULN

  • Serum creatinine < 2 times ULN OR creatinine clearance ≥ 50 mL/min

  • Not pregnant or nursing

  • Negative pregnancy test

  • Fertile patients must use effective contraception

  • No other invasive malignancy within the past 3 years, except for nonmelanomatous skin cancer or previously treated carcinoma in situ of the breast, oral cavity, or cervix

  • No simultaneous primary or bilateral tumors

  • No severe, active co-morbidity, including any of the following:

  • Unstable angina and/or congestive heart failure requiring hospitalization within the past 6 months

  • Transmural myocardial infarction within the past 6 months

  • Acute bacterial or fungal infection requiring IV antibiotics at the time of study registration

  • Chronic obstructive pulmonary disease exacerbation or other respiratory illness requiring hospitalization or precluding study therapy

  • Idiopathic pulmonary fibrosis or other severe interstitial lung disease that requires oxygen therapy or is thought to have required oxygen therapy within the past year

  • Hepatic insufficiency resulting in clinical jaundice and/or coagulation defects

  • AIDS based on current Centers for Disease Control (CDC) definition

  • Grade 3-4 electrolyte abnormalities according to CTCAE, v. 4, including any of the following:

  • Serum calcium (ionized or adjusted for albumin) < 7 mg/dL or > 12.5 mg/dL*

  • Glucose < 40 mg/dL or > 250 mg/dL

  • Magnesium < 0.9 mg/dL or > 3 mg/dL*

  • Potassium < 3.0 mmol/L or > 6 mmol/L*

  • Sodium < 130 mmol/L or > 155 mmol/L* NOTE: *Despite intervention to normalize levels.

  • No prior allergic reaction to cetuximab

PRIOR CONCURRENT THERAPY:
  • See Disease Characteristics

  • No prior systemic chemotherapy or anti-epidermal growth factor (EGF) therapy for this cancer

  • Prior chemotherapy or anti-EGF therapy for a different cancer allowed

  • No prior radiotherapy to the region of the study cancer that would result in overlap of radiotherapy fields

  • No concurrent amifostine as a radioprotector

  • No concurrent granulocyte colony-stimulating factor or erythropoietin

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Alabama at Birmingham Birmingham Alabama United States 35294
2 Arizona Oncology Associates-West Orange Grove Tucson Arizona United States 85704
3 Sutter Cancer Centers Radiation Oncology Services-Auburn Auburn California United States 95603
4 Sutter Cancer Centers Radiation Oncology Services-Cameron Park Cameron Park California United States 95682
5 Mercy San Juan Medical Center Carmichael California United States 95608
6 City of Hope Duarte California United States 91010
7 UC San Diego Moores Cancer Center La Jolla California United States 92093
8 Kaiser Permanente Los Angeles Medical Center Los Angeles California United States 90027
9 Los Angeles County-USC Medical Center Los Angeles California United States 90033
10 University of Southern California/Norris Cancer Center Los Angeles California United States 90033
11 Memorial Medical Center Modesto California United States 95355
12 Bay Area Tumor Institute CCOP Oakland California United States 94609
13 Pomona Valley Hospital Medical Center Pomona California United States 91767
14 Sutter Cancer Centers Radiation Oncology Services-Roseville Roseville California United States 95661
15 The Permanente Medical Group-Roseville Radiation Oncology Roseville California United States 95678
16 Sutter General Hospital Sacramento California United States 95816
17 University of California at Davis Cancer Center Sacramento California United States 95817
18 Mercy General Hospital Radiation Oncology Center Sacramento California United States 95819
19 Saint Helena Hospital Saint Helena California United States 94574
20 UCSF-Mount Zion San Francisco California United States 94115
21 Kaiser Permanente Medical Center - Santa Clara Santa Clara California United States 95051
22 Stanford University Hospitals and Clinics Stanford California United States 94305
23 Sutter Cancer Centers Radiation Oncology Services-Vacaville Vacaville California United States 95687
24 Rocky Mountain Cancer Centers-Aurora Aurora Colorado United States 80012
25 University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora Colorado United States 80045
26 Penrose-Saint Francis Healthcare Colorado Springs Colorado United States 80907
27 Porter Adventist Hospital Denver Colorado United States 80210
28 Swedish Medical Center Englewood Colorado United States 80113
29 Rocky Mountain Cancer Centers-Littleton Littleton Colorado United States 80120
30 Saint Vincent's Medical Center Bridgeport Connecticut United States 06606
31 Yale University New Haven Connecticut United States 06520
32 William Backus Hospital Norwich Connecticut United States 06360
33 Christiana Care Health System-Christiana Hospital Newark Delaware United States 19718
34 University of Miami Sylvester Comprehensive Cancer Center at Deerfield Beach Deerfield Beach Florida United States 33442
35 Mayo Clinic in Florida Jacksonville Florida United States 32224-9980
36 University of Miami Miller School of Medicine-Sylvester Cancer Center Miami Florida United States 33136
37 Baptist Hospital of Miami Miami Florida United States 33176
38 Florida Hospital Orlando Florida United States 32803
39 UF Cancer Center at Orlando Health Orlando Florida United States 32806
40 Emory University/Winship Cancer Institute Atlanta Georgia United States 30322
41 Atlanta VA Medical Center Decatur Georgia United States 30033
42 Northeast Georgia Medical Center Gainesville Georgia United States 30501
43 Memorial Health University Medical Center Savannah Georgia United States 31403
44 Saint Joseph's-Candler Health System Savannah Georgia United States 31405
45 Queen's Medical Center Honolulu Hawaii United States 96813
46 University of Hawaii Honolulu Hawaii United States 96813
47 The Cancer Center of Hawaii-Liliha Honolulu Hawaii United States 96817
48 Saint Alphonsus Regional Medical Center Boise Idaho United States 83706
49 John H Stroger Jr Hospital of Cook County Chicago Illinois United States 60612-3785
50 University of Illinois Chicago Illinois United States 60612
51 NorthShore University HealthSystem-Evanston Hospital Evanston Illinois United States 60201
52 Ingalls Memorial Hospital Harvey Illinois United States 60426
53 Hines Veterans Administration Hospital Hines Illinois United States 60141
54 Loyola University Medical Center Maywood Illinois United States 60153
55 Saint John's Hospital Springfield Illinois United States 62702
56 Memorial Medical Center Springfield Illinois United States 62781-0001
57 Carle Cancer Center Urbana Illinois United States 61801
58 Radiation Oncology Associates PC Fort Wayne Indiana United States 46804
59 Parkview Hospital Randallia Fort Wayne Indiana United States 46805
60 IU Health Methodist Hospital Indianapolis Indiana United States 46202
61 Community Regional Cancer Care-East Radiation Oncology Indianapolis Indiana United States 46219
62 Community Regional Cancer Care-North Indianapolis Indiana United States 46256
63 IU Health Ball Memorial Hospital Muncie Indiana United States 47303
64 McFarland Clinic PC-William R Bliss Cancer Center Ames Iowa United States 50010
65 Iowa Methodist Medical Center Des Moines Iowa United States 50309
66 Mercy Medical Center - Des Moines Des Moines Iowa United States 50314
67 University of Iowa Hospitals and Clinics Iowa City Iowa United States 52242
68 Siouxland Hematology Oncology Associates Sioux City Iowa United States 51101
69 University of Kansas Medical Center Kansas City Kansas United States 66160
70 University of Kentucky Lexington Kentucky United States 40536
71 The James Graham Brown Cancer Center at University of Louisville Louisville Kentucky United States 40202
72 Mary Bird Perkins Cancer Center Baton Rouge Louisiana United States 70809
73 Tulane University Health Sciences Center New Orleans Louisiana United States 70112
74 Touro Infirmary New Orleans Louisiana United States 70115
75 Central Maine Medical Center Lewiston Maine United States 04240
76 University of Maryland/Greenebaum Cancer Center Baltimore Maryland United States 21201
77 Peninsula Regional Medical Center Salisbury Maryland United States 21801
78 Tufts Medical Center Boston Massachusetts United States 02111
79 Boston Medical Center Boston Massachusetts United States 02118
80 Lahey Hospital and Medical Center Burlington Massachusetts United States 01805
81 Saint Joseph Mercy Hospital Ann Arbor Michigan United States 48106-0995
82 University of Michigan Ann Arbor Michigan United States 48109
83 Oakwood Hospital Dearborn Michigan United States 48124
84 Wayne State University/Karmanos Cancer Institute Detroit Michigan United States 48201
85 Henry Ford Hospital Detroit Michigan United States 48202
86 Saint John Hospital and Medical Center Detroit Michigan United States 48236
87 West Michigan Cancer Center Kalamazoo Michigan United States 49007
88 Saint Mary's of Michigan Saginaw Michigan United States 48601
89 Saint John Macomb-Oakland Hospital Warren Michigan United States 48093
90 Mercy Hospital Coon Rapids Minnesota United States 55433
91 Saint Luke's Hospital of Duluth Duluth Minnesota United States 55805
92 Unity Hospital Fridley Minnesota United States 55432
93 Minnesota Oncology Hematology PA-Maplewood Maplewood Minnesota United States 55109
94 Mayo Clinic Rochester Minnesota United States 55905
95 Regions Hospital Saint Paul Minnesota United States 55101
96 University of Mississippi Medical Center Jackson Mississippi United States 39216
97 Singing River Hospital Pascagoula Mississippi United States 39581
98 Cape Radiation Oncology Cape Girardeau Missouri United States 63703
99 University of Missouri - Ellis Fischel Columbia Missouri United States 65212
100 Kansas City Cancer Centers - North Kansas City Missouri United States 64154
101 Kansas City Cancer Center-Lee's Summit Lee's Summit Missouri United States 64064
102 Saint Louis University Hospital Saint Louis Missouri United States 63110
103 Washington University School of Medicine Saint Louis Missouri United States 63110
104 Siteman Cancer Center-South County Saint Louis Missouri United States 63129
105 Missouri Baptist Medical Center Saint Louis Missouri United States 63131
106 Barnes-Jewish West County Hospital Saint Louis Missouri United States 63141
107 Saint John's Mercy Medical Center Saint Louis Missouri United States 63141
108 Siteman Cancer Center - Saint Peters Saint Peters Missouri United States 63376
109 Mercy Hospital Springfield Springfield Missouri United States 65804
110 CoxHealth South Hospital Springfield Missouri United States 65807
111 Saint Elizabeth Regional Medical Center Lincoln Nebraska United States 68510
112 Nebraska Methodist Hospital Omaha Nebraska United States 68114
113 The Nebraska Medical Center Omaha Nebraska United States 68198
114 Renown Regional Medical Center Reno Nevada United States 89502
115 Exeter Hospital Exeter New Hampshire United States 03833
116 Dartmouth Hitchcock Medical Center Lebanon New Hampshire United States 03756
117 Memorial Sloan Kettering Cancer Center at Basking Ridge Basking Ridge New Jersey United States 07920
118 Cooper Hospital University Medical Center Camden New Jersey United States 08103
119 Fox Chase Cancer Center at Virtua Memorial Hospital of Burlington County Mount Holly New Jersey United States 08060
120 Saint Peter's University Hospital New Brunswick New Jersey United States 08901
121 UMDNJ - New Jersey Medical School Newark New Jersey United States 07103
122 Sparta Cancer Treatment Center Sparta New Jersey United States 07871
123 MD Anderson Cancer Center at Cooper-Voorhees Voorhees New Jersey United States 08043
124 University of New Mexico Albuquerque New Mexico United States 87106
125 New York Oncology Hematology PC - Albany Albany New York United States 12206
126 Maimonides Medical Center Brooklyn New York United States 11219
127 Sands Cancer Center Canandaigua New York United States 14424
128 Memorial Sloan Kettering Cancer Center Commack Commack New York United States 11725
129 Beth Israel Medical Center New York New York United States 10003
130 Memorial Sloan-Kettering Cancer Center New York New York United States 10065
131 Highland Hospital Rochester New York United States 14620
132 University Radiation Oncology Rochester New York United States 14626
133 University of Rochester Rochester New York United States 14642
134 Memorial Sloan-Kettering Cancer Center Rockville Centre Rockville Centre New York United States 11570
135 Memorial Sloan-Kettering Cancer Center at Sleepy Hallow Sleepy Hollow New York United States 10591
136 Mission Hospital-Memorial Campus Asheville North Carolina United States 28801
137 University of North Carolina Chapel Hill North Carolina United States 27599
138 Wayne Radiation Oncology Goldsboro North Carolina United States 27534
139 Kinston Medical Specialists PA Kinston North Carolina United States 28501
140 Cancer Centers of North Carolina Raleigh North Carolina United States 27607
141 Wake Forest University Health Sciences Winston-Salem North Carolina United States 27157
142 Roger Maris Cancer Center Fargo North Dakota United States 58122
143 Summa Akron City Hospital/Cooper Cancer Center Akron Ohio United States 44304
144 Akron General Medical Center Akron Ohio United States 44307
145 Summa Barberton Hospital Barberton Ohio United States 44203
146 Mercy Medical Center Canton Ohio United States 44708
147 Geaugra Hospital Chardon Ohio United States 44024
148 University of Cincinnati Cincinnati Ohio United States 45267
149 Case Western Reserve University Cleveland Ohio United States 44106
150 Cleveland Clinic Cancer Center/Fairview Hospital Cleveland Ohio United States 44111
151 Cleveland Clinic Foundation Cleveland Ohio United States 44195
152 Ohio State University Medical Center Columbus Ohio United States 43210
153 Mercy Cancer Center-Elyria Elyria Ohio United States 44035
154 Cleveland Clinic Cancer Center Independence Independence Ohio United States 44131
155 Hillcrest Hospital Cancer Center Mayfield Heights Ohio United States 44124
156 Summa Health Center at Lake Medina Medina Ohio United States 44256
157 Lake University Ireland Cancer Center Mentor Ohio United States 44060
158 Southwest General Health Center Ireland Cancer Center Middleburg Heights Ohio United States 44130
159 UHHS-Chagrin Highlands Medical Center Orange Village Ohio United States 44122
160 Saint Charles Hospital Oregon Ohio United States 43616
161 Robinson Radiation Oncology Ravenna Ohio United States 44266
162 North Coast Cancer Care Sandusky Ohio United States 44870
163 Cleveland Clinic Cancer Center-Strongsville Strongsville Ohio United States 44136
164 Flower Hospital Sylvania Ohio United States 43560
165 University Pointe West Chester Ohio United States 45069
166 UHHS-Westlake Medical Center Westlake Ohio United States 44145
167 Cleveland Clinic Wooster Specialty Center Wooster Ohio United States 44691
168 University of Oklahoma Health Sciences Center Oklahoma City Oklahoma United States 73104
169 Clackamas Radiation Oncology Center Clackamas Oregon United States 97015
170 Willamette Valley Cancer Center Eugene Oregon United States 97401
171 Providence Portland Medical Center Portland Oregon United States 97213
172 Western Oncology Research Consortium Portland Oregon United States 97213
173 Providence Saint Vincent Medical Center Portland Oregon United States 97225
174 Oregon Health and Science University Portland Oregon United States 97239
175 Portland Veterans Administration Medical Center Portland Oregon United States 97239
176 Salem Hospital Salem Oregon United States 97301
177 Lehigh Valley Hospital Allentown Pennsylvania United States 18105
178 Geisinger Medical Center Danville Pennsylvania United States 17822-2001
179 Northeast Radiation Oncology Center Dunmore Pennsylvania United States 18512
180 Pocono Medical Center East Stroudsburg Pennsylvania United States 18301
181 Adams Cancer Center Gettysburg Pennsylvania United States 17325
182 Cherry Tree Cancer Center Hanover Pennsylvania United States 17331
183 Saint Mary Medical and Regional Cancer Center Langhorne Pennsylvania United States 19047
184 University of Pennsylvania/Abramson Cancer Center Philadelphia Pennsylvania United States 19104
185 Thomas Jefferson University Hospital Philadelphia Pennsylvania United States 19107
186 Fox Chase Cancer Center Philadelphia Pennsylvania United States 19111
187 Albert Einstein Medical Center Philadelphia Pennsylvania United States 19141
188 Reading Hospital West Reading Pennsylvania United States 19611
189 WellSpan Health-York Hospital York Pennsylvania United States 17405
190 AnMed Health Cancer Center Anderson South Carolina United States 29621
191 Medical University of South Carolina Charleston South Carolina United States 29425
192 Greenville Health System Cancer Institute-Faris Greenville South Carolina United States 29605
193 Greenville Health System Cancer Institute/Greenville CCOP Greenville South Carolina United States 29615
194 Gibbs Cancer Center-Pelham Greer South Carolina United States 29651
195 Spartanburg Regional Medical Center Spartanburg South Carolina United States 29303
196 Greenville Health System Cancer Institute-Spartanburg Spartanburg South Carolina United States 29307
197 Rapid City Regional Hospital Rapid City South Dakota United States 57701
198 Sanford Cancer Center-Oncology Clinic Sioux Falls South Dakota United States 57104
199 Wellmont Holston Valley Hospital and Medical Center Kingsport Tennessee United States 37660
200 Vanderbilt-Ingram Cancer Center Nashville Tennessee United States 37232
201 Texas Oncology-Austin Midtown Austin Texas United States 78705
202 Texas Oncology - Central Austin Cancer Center Austin Texas United States 78731
203 Texas Oncology - South Austin Cancer Center Austin Texas United States 78745
204 Texas Oncology PA - Bedford Bedford Texas United States 76022
205 University of Texas Southwestern Medical Center Dallas Texas United States 75390
206 Texas Oncology-Denton South Denton Texas United States 76210
207 The Klabzuba Cancer Center Fort Worth Texas United States 76104
208 Memorial Hermann Memorial City Medical Center Houston Texas United States 77024
209 Ben Taub General Hospital Houston Texas United States 77030
210 M D Anderson Cancer Center Houston Texas United States 77030
211 Texas Oncology-Seton Williamson Round Rock Texas United States 78665
212 Texas Oncology - Round Rock Cancer Center Round Rock Texas United States 78681
213 Cancer Care Centers of South Texas- Northeast San Antonio Texas United States 78217
214 University of Texas Health Science Center at San Antonio San Antonio Texas United States 78229
215 Texas Cancer Center-Sherman Sherman Texas United States 75090
216 Texas Oncology Cancer Center Sugar Land Sugar Land Texas United States 77479
217 Texas Oncology-Wichita Falls Texoma Cancer Center Wichita Falls Texas United States 76310
218 Intermountain Medical Center Murray Utah United States 84157
219 Dixie Medical Center Regional Cancer Center Saint George Utah United States 84770
220 Utah Cancer Specialists-Salt Lake City Salt Lake City Utah United States 84106
221 Huntsman Cancer Institute/University of Utah Salt Lake City Utah United States 84112
222 LDS Hospital Salt Lake City Utah United States 84143
223 University of Virginia Charlottesville Virginia United States 22908
224 Sentara Cancer Institute at Sentara CarePlex Hospital Hampton Virginia United States 23666
225 Sentara Hospitals Norfolk Virginia United States 23507
226 Hunter Holmes McGuire Veterans Administration Medical Center Richmond Virginia United States 23249
227 Virginia Commonwealth University Richmond Virginia United States 23298
228 Sentara Virginia Beach General Hospital Virginia Beach Virginia United States 23454
229 Harrison Medical Center Bremerton Washington United States 98310
230 Tri-Cities Cancer Center Kennewick Washington United States 99336
231 Skagit Valley Hospital Mount Vernon Washington United States 98274
232 University of Washington Medical Center Seattle Washington United States 98195
233 Cancer Care Northwest - Spokane South Spokane Washington United States 99202
234 Cancer Care Northwest-North Spokane Spokane Washington United States 99218
235 Northwest CCOP Tacoma Washington United States 98405
236 PeaceHealth Southwest Medical Center Vancouver Washington United States 98664
237 Compass Oncology Vancouver Vancouver Washington United States 98684
238 Wenatchee Valley Medical Center Wenatchee Washington United States 98801
239 West Virginia University Healthcare Morgantown West Virginia United States 26506
240 Wheeling Hospital Wheeling West Virginia United States 26003
241 Langlade Hospital and Cancer Center Antigo Wisconsin United States 54409
242 Fox Valley Hematology and Oncology Appleton Wisconsin United States 54911-3496
243 Saint Vincent Hospital Green Bay Wisconsin United States 54301
244 Gundersen Lutheran La Crosse Wisconsin United States 54601
245 University of Wisconsin Hospital and Clinics Madison Wisconsin United States 53792
246 Bay Area Medical Center Marinette Wisconsin United States 54143
247 Froedtert and the Medical College of Wisconsin Milwaukee Wisconsin United States 53226
248 Clement J. Zablocki VA Medical Center Milwaukee Wisconsin United States 53295
249 Door County Cancer Center Sturgeon Bay Wisconsin United States 54235-1495
250 Aspirus Regional Cancer Center Wausau Wisconsin United States 54401
251 Cross Cancer Institute Edmonton Alberta Canada T6G 1Z2
252 CancerCare Manitoba Winnipeg Manitoba Canada R3E 0V9
253 Doctor H. Bliss Murphy Cancer Centre St. John's Newfoundland and Labrador Canada A1B 3V6
254 London Regional Cancer Program London Ontario Canada N6A 4L6
255 Ottawa Health Research Institute-General Division Ottawa Ontario Canada K1H 1C4
256 Health Sciences North Sudbury Ontario Canada P3E 5J1
257 University Health Network-Princess Margaret Hospital Toronto Ontario Canada M5G 2M9
258 CHUM - Hopital Notre-Dame Montreal Quebec Canada H2L 4M1
259 McGill University Department of Oncology Montreal Quebec Canada H2W 1S6
260 CHUQ - Pavilion Hotel-Dieu de Quebec Quebec City Quebec Canada G1R 2J6
261 Centre Hospitalier Universitaire de Sherbrooke-Fleurimont Sherbrooke Quebec Canada J1H 5N4
262 Allan Blair Cancer Centre Regina Saskatchewan Canada S4T 7T1
263 Chinese University of Hong Kong-Prince of Wales Hospital Shatin Hong Kong China OX1 3UJ
264 King Faisal Specialist Hospital and Research Centre Riyadh Saudi Arabia 11211

Sponsors and Collaborators

  • Radiation Therapy Oncology Group
  • National Cancer Institute (NCI)
  • NRG Oncology

Investigators

  • Study Chair: Mitchell Machtay, MD, University Hospitals Seidman Cancer Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Radiation Therapy Oncology Group
ClinicalTrials.gov Identifier:
NCT00956007
Other Study ID Numbers:
  • RTOG 0920
  • CDR0000651536
  • NCI-2011-00878
  • NCT01311063
First Posted:
Aug 11, 2009
Last Update Posted:
Aug 4, 2021
Last Verified:
Aug 1, 2021

Study Results

No Results Posted as of Aug 4, 2021